Susquehanna International Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-653,300
| Closed | -$12.3M | – | 11233 |
|
|
2019
Q3 | $12.3M | Buy |
653,300
+612,800
| +1,513% | +$7.01M | ﹤0.01% | 1761 |
|
|
2019
Q2 | $477K | Buy |
40,500
+27,900
| +221% | +$338K | ﹤0.01% | 7370 |
|
|
2019
Q1 | $172K | Buy |
+12,600
| New | +$163K | ﹤0.01% | 7963 |
|
|
2018
Q4 | – | Sell |
-30,100
| Closed | -$501K | – | 10486 |
|
|
2018
Q3 | $501K | Sell |
30,100
-181,600
| -86% | -$3.28M | ﹤0.01% | 6526 |
|
|
2018
Q2 | $3.35M | Sell |
211,700
-87,300
| -29% | -$1.33M | ﹤0.01% | 3247 |
|
|
2018
Q1 | $3.8M | Buy |
299,000
+219,000
| +274% | +$3.17M | ﹤0.01% | 2896 |
|
|
2017
Q4 | $916K | Sell |
80,000
-14,700
| -16% | -$164K | ﹤0.01% | 5415 |
|
|
2017
Q3 | $1.16M | Sell |
94,700
-17,800
| -16% | -$186K | ﹤0.01% | 5011 |
|
|
2017
Q2 | $1.29M | Buy |
112,500
+70,700
| +169% | +$1.31M | ﹤0.01% | 4741 |
|
|
2017
Q1 | $869K | Buy |
41,800
+14,300
| +52% | +$317K | ﹤0.01% | 5426 |
|
|
2016
Q4 | $572K | Sell |
27,500
-7,400
| -21% | -$192K | ﹤0.01% | 6704 |
|
|
2016
Q3 | $1.14M | Sell |
34,900
-22,800
| -40% | -$694K | ﹤0.01% | 4541 |
|
|
2016
Q2 | $1.44M | Buy |
57,700
+21,100
| +58% | +$571K | ﹤0.01% | 4145 |
|
|
2016
Q1 | $896K | Sell |
36,600
-4,900
| -12% | -$113K | ﹤0.01% | 5303 |
|
|
2015
Q4 | $1.37M | Sell |
41,500
-125,600
| -75% | -$4.25M | ﹤0.01% | 4777 |
|
|
2015
Q3 | $5.47M | Buy |
167,100
+77,700
| +87% | +$3.3M | ﹤0.01% | 2545 |
|
|
2015
Q2 | $4.74M | Buy |
+89,400
| New | +$3.25M | ﹤0.01% | 2997 |
|